Japan Breast Cancer Research Group
Clinical trials sponsored by Japan Breast Cancer Research Group, explained in plain language.
-
New hope for advanced breast cancer: trial tests alternative drug combo
Disease control CompletedThis study compared two different three-drug combinations for treating advanced or returning HER2-positive breast cancer. Researchers tested whether adding eribulin to standard drugs works as well as adding taxane chemotherapy, while aiming for fewer side effects like numbness. T…
Phase: PHASE3 • Sponsor: Japan Breast Cancer Research Group • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Can a drug work a second time? trial tests retreatment for tough breast cancers
Disease control CompletedThis study tested whether restarting a drug called pertuzumab, along with standard treatments, could help control advanced HER2-positive breast cancer that had previously been treated with it. It involved 226 women with advanced breast cancer. The goal was to see if this retreatm…
Phase: PHASE3 • Sponsor: Japan Breast Cancer Research Group • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC